Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Triple-blinded, Randomized, Parallel-group Placebo-controlled Trial to Assess the Impact of Maternal Antenatal Melatonin Supplementation on Early Childhood Neurodevelopmental Outcomes in the Setting of Severe Preterm Fetal Growth Restriction

NCT05651347 is registered in ClinicalTrials.gov with Monash University as lead sponsor.

NCT NCT05651347
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05651347 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Triple-blinded, Randomized, Parallel-group Placebo-controlled Trial to Assess the Impact of Maternal Antenatal Melatonin Supplementation on Early Childhood Neurodevelopmental Outcomes in the Setting of Severe Preterm Fetal Growth Restriction
Lead sponsor
Monash University
Phase
Phase 3
Overall status
Recruiting
Start date
May 29, 2019
Completion date
April 30, 2027
Enrollment
336 (estimated)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

fetal growth retardation, pregnancy preterm, stillbirth and fetal death